Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome (DS): 3-Year Interim Results of an Open-Label Extension (OLE) Trial (GWPCARE5)

被引：0
|
作者：
Halford, Jonathan J. [1 ]
Scheffer, Ingrid [2 ,3 ]
Nabbout, Rima [4 ]
Sanchez-Carpintero, Rocio [5 ]
Malawky, Yael Shiloh [6 ]
Wong, Matthew [7 ]
Checketts, Daniel [8 ]
Dunayevich, Eduardo [9 ]
机构：
[1] Med Univ South Carolina, Dept Neurol, Translat Res Unit, Charleston, SC 29425 USA
[2] Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia
[3] Royal Childrens Hosp, Melbourne, Vic, Australia
[4] Necker Enfants Malades Hosp, Paris, France
[5] Clin Univ Navarra, Pamplona, Spain
[6] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[7] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[8] GW Res Ltd, Carlsbad, CA USA
[9] Greenwich Biosci Inc, Carlsbad, CA USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
439
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study
    Ng, Yu-Tze
    Conry, Joan
    Paolicchi, Juliann
    Kernitsky, Lydia
    Mitchell, Wendy
    Drummond, Rebecca
    Isojarvi, Jouko
    Lee, Deborah
    Owen, Randall
    EPILEPSY & BEHAVIOR, 2012, 25 (04) : 687 - 694
  • [32] Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study
    Trauner, Michael
    Nevens, Frederik
    Shiffman, Mitchell L.
    Drenth, Joost P. H.
    Bowlus, Christopher L.
    Vargas, Victor
    Andreone, Pietro
    Hirschfield, Gideon M.
    Pencek, Richard
    Malecha, Elizabeth Smoot
    MacConell, Leigh
    Shapiro, David
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (06): : 445 - 453
  • [33] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [34] Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
    Inoue, Yushi
    Ohtsuka, Yoko
    EPILEPSY RESEARCH, 2015, 113 : 90 - 97
  • [35] Long-term safety and efficacy of transdermal rotigotine in idiopathic RLS: 3-year results from a multinational open-label trial
    Garcia-Borreguero, D.
    Poewe, W.
    Hoegl, B.
    Kohnen, R.
    Stiasny-Kolste, K.
    Keffel, J.
    Schollmayer, E.
    Boroojerdi, B.
    Trenkwalder, C.
    Oertel, W. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 110 - 110
  • [36] 3-YEAR INTERIM ANALYSIS RESULTS OF VISION TRIAL: A RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF VONOPRAZAN AS MAINTENANCE TREATMENT IN PATIENTS WITH EROSIVE ESOPHAGITIS
    Haruma, Ken
    Uemura, Naomi
    Kinoshita, Yoshikazu
    Yao, Takashi
    Kushima, Ryoji
    Akiyama, Junichi
    Kanoo, Tatsuhiro
    Miyata, Kouji
    GASTROENTEROLOGY, 2021, 160 (06) : S447 - S447
  • [37] Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study
    Lai, Wyman W.
    Galer, Bradley S.
    Wong, Pierre C.
    Farfel, Gail
    Pringsheim, Milka
    Keane, Martin G.
    Agarwal, Anupam
    EPILEPSIA, 2020, 61 (11) : 2386 - 2395
  • [38] Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results
    Fleischer, David M.
    Shreffler, Wayne G.
    Campbell, Dianne E.
    Green, Todd D.
    Anvari, Sara
    Assa'ad, Amal
    Begin, Philippe
    Beyer, Kirsten
    Bird, J. Andrew
    Brown-Whitehorn, Terri
    Byrne, Aideen
    Chan, Edmond S.
    Cheema, Amarjit
    Chinthrajah, Sharon
    Chong, Hey Jin
    Davis, Carla M.
    Ford, Lara S.
    Gagnon, Remi
    Greenhawt, Matthew
    Hourihane, Jonathan O'B
    Jones, Stacie M.
    Kim, Edwin H.
    Lange, Lars
    Lanser, Bruce J.
    Leonard, Stephanie
    Mahler, Vera
    Maronna, Andreas
    Nowak-Wegrzyn, Anna
    Oriel, Roxanne C.
    O'Sullivan, Michael
    Petroni, Daniel
    Pongracic, Jacqueline A.
    Prescott, Susan L.
    Schneider, Lynda C.
    Smith, Peter
    Staab, Doris
    Sussman, Gordon
    Wood, Robert
    Yang, William H.
    Lambert, Romain
    Peillon, Aurelie
    Bois, Timothee
    Sampson, Hugh A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (04) : 863 - 874
  • [39] Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial
    Thiele, Elizabeth A.
    Bebin, E. Martina
    Filloux, Francis
    Kwan, Patrick
    Loftus, Rachael
    Sahebkar, Farhad
    Sparagana, Steven
    Wheless, James
    EPILEPSIA, 2022, 63 (02) : 426 - 439
  • [40] Long-Term (2-Year) Safety and Efficacy of Adjunctive ZX008 (Fenfluramine Hydrochloride Oral Solution) for Dravet Syndrome: Interim Results of an Ongoing Open-Label Extension Study
    Sullivan, Joseph
    Auvin, Stephane
    Pringsheim, Milka
    Knupp, Kelly
    Wirrell, Elaine
    Farfel, Gail
    Galer, Bradley
    Morrison, Glenn
    Lock, Michael
    Gammaitoni, Arnold
    Thiele, Elizabeth
    NEUROLOGY, 2020, 94 (15)
12345